by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Nova Vascular LLC dba NOVARX Warning Letter Details

Warning Letter

Nova Vascular LLC dba NOVARX

99 Wall Street, #878 New York , NY 10005 United States

Issue DateJune 08, 2026

FEI NumberN/A

Violations1

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

False & Misleading Claims/Misbranded (Telehealth)

Nova Vascular LLC dba NOVARX FDA Warning Letter, June 8, 2026